Earlier prime-BOOST schedule to improve MEasles protection in high burden settings
Bill and Melinda Gates Foundation
Type of Study
University of Oxford
Dr Ezekiel Mupere
The study aims to compare the safety and immunogenicity of early (6 months) vs standard (9 months) dosing with measles-containing vaccine, in Ugandan children.
This study is currently in set-up phase. More details are to be shared later.